Mesoblast have been going about there business of advancing...

Mesoblast have been going about there business of advancing there trials.While the market is doing what it normally does. Mesoblast will have 5 major diseases (Tier 1) that it can treat with its products in the market place on the outcome of successfull phase 3 trials.1.Heart failure,2.Diabetes 2 (Renal complications),3.Lower back pain4.Rhuematuid arthrithis,5.GVHD.The first product GVHD is already in the market (Japan second biggest health care market in the world) also approved In Canada and New Zealand with first sales next month.So to all the non believers and shorters who are trying to pick up cheap shares this is really happening right now so prepare for lift off.